David S. Wetherell

Fondateur chez Biomark Capital Management Co. LLC

Profil

David S.
Wetherell founded Navisite LLC in 1996, where he worked as Chairman in 2000, Engage Technologies, Inc. in 1996, where he worked as Chairman in 2000, GBP Capital in 2005, where he worked as Managing Partner from 2010 to 2011, and Biomark Capital Management Co. LLC in 2013, where he is working as Managing Partner.
Mr. Wetherell also currently works at TMune Therapeutics, Inc., as Director, HyperMed Imaging, Inc., as Director, and Lentigen Technology, Inc., as Director.
Mr. Wetherell also formerly worked at CMGI, Inc., as Chairman from 1986 to 2006, Opus Bio, Inc., as Chairman, Club Holdings LLC, as Director, ADMA Biologics, Inc., as Director, WhiteGlove Health, Inc., as Director, MabVax Therapeutics, Inc., as Director, Burrill LLC, as Managing Director in 2012, Quintess LLC, as Director from 2004 to 2009, Strand Life Sciences Pvt Ltd., as Director, Spectral Image, Inc., as Director, Flexible Stenting Solutions, Inc., as Director from 2008 to 2010, and CMG @Ventures, Inc., as Consultant.
Mr. Wetherell received his undergraduate degree in 1976 from Ohio Wesleyan University and graduate degree from the University of Iowa College of Education.

Postes actifs de David S. Wetherell

Sociétés	Poste	Début
TMune Therapeutics, Inc.	Directeur/Membre du Conseil	-
HyperMed Imaging, Inc.	Directeur/Membre du Conseil	-
Biomark Capital Management Co. LLC	Fondateur	01/11/2013
Lentigen Technology, Inc.	Directeur/Membre du Conseil	-

Anciens postes connus de David S. Wetherell

Sociétés	Poste	Fin
Burrill LLC	Private Equity Investor	31/10/2013
GBP Capital	Fondateur	31/12/2011
Flexible Stenting Solutions, Inc.	Directeur/Membre du Conseil	31/12/2010
Quintess LLC	Directeur/Membre du Conseil	31/12/2009
CMGI, Inc.	Président	31/08/2006

Formation de David S. Wetherell

Ohio Wesleyan University	Undergraduate Degree
University of Iowa College of Education	Graduate Degree